Dowling & Yahnke’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $175K | Sell |
10,691
-590
| -5% | -$9.66K | 0.01% | 355 |
|
|
2022
Q2 | $164K | Hold |
11,281
| – | – | 0.01% | 359 |
|
|
2022
Q1 | $208K | Hold |
11,281
| – | – | 0.01% | 357 |
|
|
2021
Q4 | $268K | Hold |
11,281
| – | – | 0.01% | 332 |
|
|
2021
Q3 | $278K | Sell |
11,281
-2,460
| -18% | -$60.6K | 0.02% | 317 |
|
|
2021
Q2 | $340K | Hold |
13,741
| – | – | 0.02% | 295 |
|
|
2021
Q1 | $300K | Buy |
+13,741
| New | +$300K | 0.02% | 292 |
|